Re: I-SPY 2 trial qualifies neratinib for HER2-positive breast cancer
What are MP+ tumors? Anyone?
This is better, but where are the studies that show personalized treatment instead of randomized?
If everyone thinks they are getting the best treatment it negates the placebo effect.
At least it gets drugs approved for some, but we are still shooting at cancer with shotguns instead of rifles.
|